QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)

IXICO (IXI) Competitors

GBX 8.69
-0.06 (-0.69%)
(As of 02:11 PM ET)

IXI vs. OCTP, FAB, VAL, BSFA, GENF, APTA, ROQ, EVG, NFX, and PYC

Should you be buying IXICO stock or one of its competitors? The main competitors of IXICO include Oxford Cannabinoid Technologies (OCTP), Fusion Antibodies (FAB), ValiRx (VAL), BSF Enterprise (BSFA), Genflow Biosciences (GENF), Aptamer Group (APTA), Roquefort Therapeutics (ROQ), Evgen Pharma (EVG), Nuformix (NFX), and Physiomics (PYC). These companies are all part of the "biotechnology" industry.

IXICO vs.

IXICO (LON:IXI) and Oxford Cannabinoid Technologies (LON:OCTP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk.

IXICO has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Oxford Cannabinoid Technologies has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IXICO
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Oxford Cannabinoid Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

IXICO has higher revenue and earnings than Oxford Cannabinoid Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IXICO£6.67M0.63-£1.18M-£0.02-434.50
Oxford Cannabinoid TechnologiesN/AN/A-£4.24MN/AN/A

56.9% of IXICO shares are held by institutional investors. Comparatively, 14.1% of Oxford Cannabinoid Technologies shares are held by institutional investors. 29.0% of IXICO shares are held by insiders. Comparatively, 29.8% of Oxford Cannabinoid Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

IXICO received 144 more outperform votes than Oxford Cannabinoid Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
IXICOOutperform Votes
144
71.64%
Underperform Votes
57
28.36%
Oxford Cannabinoid TechnologiesN/AN/A

In the previous week, IXICO had 1 more articles in the media than Oxford Cannabinoid Technologies. MarketBeat recorded 1 mentions for IXICO and 0 mentions for Oxford Cannabinoid Technologies. IXICO's average media sentiment score of 0.99 beat Oxford Cannabinoid Technologies' score of 0.00 indicating that IXICO is being referred to more favorably in the media.

Company Overall Sentiment
IXICO Positive
Oxford Cannabinoid Technologies Neutral

Oxford Cannabinoid Technologies has a net margin of 0.00% compared to IXICO's net margin of -17.67%. IXICO's return on equity of -9.85% beat Oxford Cannabinoid Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
IXICO-17.67% -9.85% -6.50%
Oxford Cannabinoid Technologies N/A -86.76%-53.92%

Summary

IXICO beats Oxford Cannabinoid Technologies on 8 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IXI vs. The Competition

MetricIXICOBiotechnology IndustryMedical SectorLON Exchange
Market Cap£4.20M£158.65M£4.81B£1.36B
Dividend Yield1.27%3.48%2.99%11.99%
P/E Ratio-434.50243.16170.091,713.74
Price / Sales0.6315,083.142,390.54310,720.11
Price / Cash2.2511.3446.7732.83
Price / Book0.365.694.582.50
Net Income-£1.18M-£19.23M£103.72M£179.61M
7 Day Performance-0.05%-1.36%-3.79%-0.57%
1 Month Performance4.15%-3.14%-5.29%7.74%
1 Year Performance-56.59%53.93%7.30%15.99%

IXICO Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCTP
Oxford Cannabinoid Technologies
0 of 5 stars
GBX 0.35
-0.6%
N/A-68.0%£3.85MN/A-53.107Gap Up
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.84
+1.1%
N/A-89.0%£3.66M£1.58M-42.6748Gap Down
VAL
ValiRx
0 of 5 stars
GBX 3.50
-3.4%
N/A-66.3%£4.63MN/A-116.678Gap Down
BSFA
BSF Enterprise
0 of 5 stars
GBX 4.78
-9.0%
N/A-74.4%£4.94MN/A-239.0012Gap Down
GENF
Genflow Biosciences
0 of 5 stars
GBX 1.50
-5.1%
N/A-64.2%£5.25MN/A-256.005Gap Down
APTA
Aptamer Group
0 of 5 stars
GBX 0.53
flat
N/A-97.9%£2.45M£1.03M-6.5637Gap Up
ROQ
Roquefort Therapeutics
0 of 5 stars
GBX 4.55
flat
N/A-36.6%£5.88M£637.00-381.259News Coverage
EVG
Evgen Pharma
0 of 5 stars
GBX 0.75
-3.2%
N/A-79.1%£2.06MN/A-75.0010News Coverage
Gap Down
NFX
Nuformix
0 of 5 stars
GBX 0.21
flat
N/A-19.0%£1.68M£50,000.00-1.633Gap Down
PYC
Physiomics
0 of 5 stars
GBX 1.19
-1.0%
N/A-60.4%£1.61M£900,707.00-13.8310News Coverage
Gap Down

Related Companies and Tools

This page (LON:IXI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners